Zika virus — what clinicians need to know
Published Date:January 26, 2016
Up-to-Date Info:To find the latest CDC information on this topic go to: http://www.cdc.gov/zika/index.html
Corporate Authors:Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of Emergency Operations. ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. ; National Center on Birth Defects and Developmental Disabilities (U.S.). Division of Birth Defects and Developmental Disabilities.
Description:Zika virus : the latest emerging arbovirus in the Americas / Ingrid Rabe -- Zika virus and pregnancy / Dana Meaney-Delman -- Zika virus and microcephaly / Cynthia A. Moore.
Clinician Outreach and Communication Activity (COCA) webinar, Tuesday, January 26, 2016 ,
Zika virus is a mosquito-borne flavivirus transmitted primarily by Aedes aegypti mosquitoes and an estimated 80% of persons infected with Zika virus are asymptomatic. Symptomatic disease is generally mild, with symptoms of fever, maculopapular rash, arthralgia, or nonpurulent conjunctivitis that typically last from several days to one week. Sporadic cases and outbreaks of Zika virus disease have occurred in countries in Africa and Southeast Asia. In 2015, the first local Zika virus transmission in the Americas was reported in Brazil and local transmission has now been in several countries or territories in the Americas. In the current outbreak in Brazil, a marked increase in the number of infants born with microcephaly has been reported and Zika virus infections have been confirmed in some infants with microcephaly. However, it is not known how many of the microcephaly cases are associated with Zika virus infection. Travelers to areas with ongoing outbreaks are at risk of becoming infected and spreading the virus to new areas, including the continental United States. During this COCA Call, participants will learn about the epidemiology and clinical manifestation of Zika virus disease and how early recognition and reporting of suspected cases can mitigate the risk of local transmission.
At the conclusion of the session, the participant will be able to accomplish the following:
• Describe the epidemiology, clinical manifestations, management, and prevention of Zika virus disease
• Discuss diagnostic testing for Zika virus infection and interpretation of test results
• Articulate the importance of early recognition and reporting of cases
• State the recommendations for pregnant women and possible Zika virus exposure
• Discuss evaluation of infants with microcephaly and the relationship of Zika and microcephaly
Supporting Files:No Additional Files
You May Also Like: